Zobrazeno 1 - 10
of 31
pro vyhledávání: '"J P G Sluijter"'
Autor:
Martinus I. F. J. Oerlemans, Jesse F. Veenis, J. P. G. Sluijter, N. de Jonge, Sandra Crnko, L. W. van Laake, Jasper J. Brugts
Publikováno v:
Netherlands Heart Journal
Netherlands Heart Journal, 29(7-8), 409-414. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29(7-8), 409-414. Bohn Stafleu van Loghum
Aims The CardioMEMS HF system is used to measure pulmonary artery (PA) pressures of patients with heart failure (HF). The goal of this study was to determine the impact of time in the daily PA pressure measurements, considering variance and influence
Autor:
P. P. Zwetsloot, L. H. J. A. Kouwenberg, E. S. Sena, J. E. Eding, H. M. den Ruijter, J. P. G. Sluijter, G. Pasterkamp, P. A. Doevendans, I. E. Hoefer, S. A. J. Chamuleau, G. P. J. van Hout, S. J. Jansen of Lorkeers
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Externí odkaz:
https://doaj.org/article/2b03aeaaaac5436981f91d36c4d6567c
Publikováno v:
European Heart Journal. 42
Background Ischemic heart disease remains the leading cause of death worldwide due to irreversible loss of cardiomyocytes (CMs) during ischemic injury. To test potential factors that can stimulate cardiac repair, murine and porcine animal models or i
Autor:
L. W. van Laake, B C Du Pre, Hendrik Gremmels, Sandra Crnko, V M Sampiao Pinto, J. P. G. Sluijter, A B Kilgallen, S.C.A. de Jager, Dries A.M. Feyen, R Reijers, F Van Der Akker, P. A. F. M. Doevendans
Publikováno v:
European Heart Journal. 42
Aim Circadian rhythms control many physiological processes, including numerous aspects of the immune system. Whether these immunological oscillations play a role in the pathophysiology after ischemic injury, such as myocardial infarction (MI), remain
Autor:
R Maas, S Lee, M Harakalova, W R Goodyer, P F M Doevendans, J Van Der Velden, F W Asselbergs, J P G Sluijter, S M Wu, J B Buikema
Publikováno v:
European Heart Journal. 42
Introduction Over the past decade, various protocols were established to ensure efficient differentiation of hiPSC into cardiomyocytes (CMs). A major limitation, however, remained the batch-to-batch variability of hiPSC-CM efficiency and cell number.
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Background. After myocardial infarction (MI), the inflammatory response is indispensable for initiating reparatory processes. However, the intensity and duration of the inflammation cause additional damage to the already injured myocardium. Treatment
Externí odkaz:
https://doaj.org/article/cf10ad18b4ad4ceb97d116d60bcff7bd
Autor:
P. A. F. M. Doevendans, M. Huibers, P. van den Hoogen, N. de Jonge, J. P. G. Sluijter, E. Siera, S.C.A. de Jager, R.A. de Weger, A. Vink, F.W. van den Dolder
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S500-S501
Purpose It is difficult to predict which patients will have a long term survival after heart transplantation (HTx). Cardiac allograft vasculopathy (CAV) and antibody mediated rejection are long-term morbidities after HTx limiting survival. Both are c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P. P. Zwetsloot, L. H. J. A. Kouwenberg, E. S. Sena, J. E. Eding, H. M. den Ruijter, J. P. G. Sluijter, G. Pasterkamp, P. A. Doevendans, I. E. Hoefer, S. A. J. Chamuleau, G. P. J. van Hout, S. J. Jansen of Lorkeers
Publikováno v:
Scientific Reports, 7(1). Nature Publishing Group
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Zwetsloot, P P, Kouwenberg, L H J A, Sena, E S, Eding, J E, Den Ruijter, H M, Sluijter, J P G, Pasterkamp, G, Doevendans, P A, Hoefer, I E, Chamuleau, S A J, Van Hout, G P J & Jansen Of Lorkeers, S J 2017, ' Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies ', Scientific Reports, vol. 7, no. 1 . https://doi.org/10.1038/s41598-017-14294-z
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Zwetsloot, P P, Kouwenberg, L H J A, Sena, E S, Eding, J E, Den Ruijter, H M, Sluijter, J P G, Pasterkamp, G, Doevendans, P A, Hoefer, I E, Chamuleau, S A J, Van Hout, G P J & Jansen Of Lorkeers, S J 2017, ' Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies ', Scientific Reports, vol. 7, no. 1 . https://doi.org/10.1038/s41598-017-14294-z
Scientific Reports
Large animal models are essential for the development of novel therapeutics for myocardial infarction. To optimize translation, we need to assess the effect of experimental design on disease outcome and model experimental design to resemble the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b7478ec5bade973eec7c5519b0df41
https://dspace.library.uu.nl/handle/1874/356640
https://dspace.library.uu.nl/handle/1874/356640
Autor:
T. I. G. van der Spoel, W. A. Gathier, S. Koudstaal, F. van Slochteren, S. Jansen of Lorkeers, J. P. G. Sluijter, I. E. Hoefer, P. Steendijk, M. J. M. Cramer, P. A. Doevendans, E. van Belle, S. A. J. Chamuleau
Publikováno v:
Journal of Cardiovascular Translational Research
Journal of Cardiovascular Translational Research, 8(7), 393. Springer New York
Journal of Cardiovascular Translational Research, 8(7), 393-403
Journal of Cardiovascular Translational Research, 8(7), 393. Springer New York
Journal of Cardiovascular Translational Research, 8(7), 393-403
Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a comparison between autologous bone marrow-derived mononuclear cells (BMMNC) and mesenchymal st